approval · primary record
CASIMERSEN
FDA · NDA · 2026-01-06
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-01-06 |
| Brand | AMONDYS 45 |
| Sponsor | SAREPTA THERAPS INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:02.013Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CASIMERSEN:2026-01-06
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.